Litcius/Paper detail

Management of challenging myelofibrosis after JAK inhibitor failure and/or progression

Robyn M. Scherber, Ruben A. Mesa

2020Blood Reviews28 citationsDOIOpen Access PDF

Topics & Concepts

RuxolitinibMyelofibrosisMedicineClinical trialInternal medicineDosingMyeloproliferative neoplasmOncologyIntensive care medicinePolycythemia veraBone marrowMyeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia ResearchKruppel-like factors research
Management of challenging myelofibrosis after JAK inhibitor failure and/or progression | Litcius